Effects of sodium butyrate in animal models of mania and depression: Implications as a new mood stabilizer

Behavioural Pharmacology

Volumn 24, Issue 7, 2013, Pages 569-579

  Resende, Wilson R ^a   Valvassori, Samira S ^a   Réus, Gislaine Z ^a   Varela, Roger B ^a   Arent, Camila O ^a   Ribeiro, Karine F ^a   Bavaresco, Daniela V ^a   Andersen, Monica L ^b   Zugno, Alexandra I ^a   Quevedoa, Joaõ ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal model; Bipolar disorder; Depression; Mania; Rat; Sodium butyrate

Indexed keywords

BUTYRIC ACID; DEXAMPHETAMINE; IMIPRAMINE; MOOD STABILIZER; OUABAIN; SODIUM CHLORIDE; TRANQUILIZER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; FOOD INTAKE; FORCED SWIMMING TEST; IMMOBILITY; LOCOMOTION; MALE; MANIA; MATERNAL DEPRIVATION; NONHUMAN; OPEN FIELD TEST; RAT; AFFECT; ANIMAL; ANIMAL BEHAVIOR; BIPOLAR DISORDER; DISEASE MODEL; DRUG EFFECTS; PATHOPHYSIOLOGY; WISTAR RAT;

AFFECT; ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; BUTYRIC ACID; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, WISTAR;

EID: 84888302218     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32836546fc     Document Type: Article

References (76)

1. Arent CO, Valvassori SS, Fries GR, Stertz L, Ferreira CL, Lopes-Borges J, et al. (2011). Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Mol Neurobiol 43:207-214.
2. Azab AN, Mehta DV, Chesebro JE, Greenberg ML (2009). Ethylbutyrate, a valproate-like compound, exhibits inositol-depleting effects-a potential mood-stabilizing drug. Life Sci 84:38-44.
3. Banasr M, Duman RS (2007). Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 6:311-320.
4. Banerjee U, Dasgupta A, Rout JK, Singh OP (2012). Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 37:56-61.
5. Barros DM, Izquierdo LA, SantAnna MK, Quevedo J, Medina JH, McGaugh JL, et al. (1999). Stimulators of the cAMP cascadereverse amnesia induced by intra-amygdala but not intrahippocampal KN-62 administration. Neurobiol Learn Mem 71:94-103.
6. Berggren U, Tallstedt L, Ahlenius S, Engel J (1978). The effect of lithium on amphetamine-induced locomotor stimulation. Psychopharmacology (Berl) 59:41-45.
7. Berk M, Dodd S, Kauer-Santanna M, Malhi GS, Bourin M, Kapczinski F, Norman T (2007). Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 434:41-49.
8. Berridge MJ, Downes CP, Hanley MR (1982). Lithium amplifies agonistdependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206:587-595.
9. Berridge MJ, Irvine RF (1989). Inositol phosphates and cell signalling. Nature 341:197-205.
10. Brocardo PS, Budni J, Pavesi E, Franco JL, Uliano-Silva M, Trevisan R, et al. (2010). Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disord 2:414-424.
11. Brownell JE, Allis CD (1996). Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6:176-184.
12. Castren E, Voikar V, Rantamaki T (2007). Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21.
13. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, et al. (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11:1116-1125.
14. Chen S, Owens GC, Makarenkova H, Edelman DB (2010). HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One 26:10848.
15. Davies JA, Jackson B, Redfern PH (1974). The effect of amantadine, L-dopa, (plus)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response. Neuropharmacology 13:199-204.
16. De Sarno P, Li X, Jope RS (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158-1164.
17. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72.
18. Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, et al. (2003). Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23:9162-9170.
19. Duman R, Monteggia LM (2006). A neurotrophic model for stress related mood disorders. Biol Psychiatry 59:1116-1127.
20. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, et al. (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311-7316.
21. El-Mallakh RS (1983). The Na, K-ATPase hypothesis for manic depression. I. General considerations. Med Hypotheses 12:253-268.
22. El-Mallakh RS,Wyatt RJ (1995). The Na, K-ATPase hypothesis for bipolar illness. Biol Psychiatry 37:235-244.
23. El-Mallakh RS, Harrison LT, Li R, Changaris DG, Levy RS (1995). An animal model for mania: preliminary results. Prog Neuropsychopharmacol Biol Psychiatry 19:955-962.
24. El-Mallakh RS, El-Masri MA, Huff MO, Li XP, Decker S, Levy RS (2003). Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 5:362-365.
25. Ferland CL, Schrader LA (2011). Regulation of histone acetylation in the hippocampus of chronically stressed rats: A potential role of sirtuins. Neuroscience 174:104-114.
26. Fernandes BS, Gama CS, Ceresé r KM, Yatham LN, Fries GR, Colpo G, et al. (2011). Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res 45:995-1004.
27. Frey BN, Andreazza AC, Ceresé r KM, Martins MR, Valvassori SS, Réus GZ, et al. (2006a). Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281-286.
28. Frey BN, Valvassori SS, Réus GZ, Martins MR, Petronilho FC, Bardini K, et al. (2006b). Changes in antioxidant defense enzymes after D-amphetamine exposure: Implications as an animal model of mania. Neurochem Res 31:699-703.
29. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158:100-106.
30. Gamaro GD, Manoli LP, Torres IL, Silveira R, Dalmaz C (2003). Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem Int 42:107-114.
31. Gao Y, Payne RS, Schurr A, Hougland T, Lord J, Herman L, et al. (2011). Memantine reduces mania-like symptoms in animal models. Psychiatry Res 188:366-371.
32. Go ttlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, et al. (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 17:6969-6978.
33. Gould TJ, Keith RA, Bhat RV (2001). Differential sensitivity to lithiums reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behav Brain Res 118:95-105.
34. Gra ff J, Tsai LH (2013). Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 14:97-111.
35. Gundersen BB, Blendy JA (2009). Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 57:67-74.
36. Huff MO, Li XP, Ginns E, El-Mallakh RS (2010). Effect of ethacrynic acid on the sodium-and potassium-activated adenosine triphosphatase activity and expression in Old Order Amish bipolar individuals. J Affect Disord 123:303-307.
37. Jornada LK, Moretti M, Valvassori SS, Ferreira CL, Padilha PT, Arent CO, et al. (2010). Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. J Psychiatr Res 44:506-510.
38. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, et al. (2003). Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 6:127-137.
39. Kato T, Kato N (2000). Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180-190.
40. Kato T, Kunugi H, Nanko S, Kato N (2001). Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord 62:151-164.
41. Katz RJ (1981). Animal models and human depressive disorders. Neurosci Biobehav Rev 5:231-246.
42. Kim HJ, Leeds P, Chuang DM (2009). The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 110: 1226-1240.
43. Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455-8459.
44. Koo J, Duman RS (2009). Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Invest Drugs 10: 664-671.
45. Krishnan V, Nestler EJ (2010). Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167:1305-1320.
46. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, et al. (2007). Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 9:531-535.
47. Leng Y, Liang MH, Ren M, Marinova Z, Leeds P, Chuang DM (2008). Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 28:2576-2588.
48. Lin PY (2009). State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: A meta-analytic study. Neurosci Lett 466:139-143.
49. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM,Wood MA (2010). Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 67:36-43.
50. Mello PB, Benetti F, Cammarota M, Izquierdo I (2009). Physical exercise can reverse the deficit in fear memory induced by maternal deprivation. Neurobiol Learn Mem 92:364-369.
51. Moretti M, Valvassori SS, Varela RB, Ferreira CL, Rochi N, Benedet J, et al. (2011). Behavioral and neurochemical effects of sodium butyrate in an animal model of mania. Behav Pharmacol 22:766-772.
52. Morita K, Her S (2008). Progesterone pretreatment enhances serotoninstimulated BDNF gene expression in rat C6 glioma cells through production of 5a-reduced neurosteroids. J Mol Neurosci 34:193-200.
53. Morita K, Gotohda T, Arimochi H, Lee MS, Her S (2009). Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. J Neurosci Res 87:2608-2614.
54. Mu ller-Oerlinghausen B, Bergho fer A, Bauer M (2002). Bipolar disorder. Lancet 359:241-247.
55. Murashita J, Kato T, Shioiri T, Inubushi T, Kato N (2000). Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy. Psychol Med 30:107-115.
56. Nestler EJ, Hyman SE (2010). Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161-1169.
57. Petit-Demouliere B, Chenu F, Bourin M (2005). Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology (Berl) 177:245-255.
58. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741.
59. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730-732.
60. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391.
61. Riegel RE, Valvassori SS, Elias G, Ré us GZ, Steckert AV, de Souza B, et al. (2009). Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochem Int 55: 491-495.
62. Salminen A, Tapiola T, Korhonen P, Suuronen T (1998). Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res Mol Brain Res 61: 203-206.
63. Schroeder FA, Lin CL, CrusioWE, Akbarian S (2007). Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62:55-64.
64. Schmidt H, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18:391-418.
65. Shahbazian MD, Grunstein M (2007). Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76:75-100.
66. Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370.
67. Tramontina J, Frey BN, Andreazza AC, Zandona M, Santin A, Kapczinski F (2007). Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry 12:230-231.
68. Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Gonçalves CL, Cardoso MR, et al. (2010). Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with D-amphetamine. J Psychiatr Res 44: 903-909.
69. Vazquez V, Farley S, Giros B, Daugé V (2005). Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260. Psychopharmacology (Berl) 181706-713.
70. Weaver A, Richardson R, Worlein J, De Waal F, Laudenslager M (2004). Response to social challenge in young bonnet (Macaca radiata) and pigtail (Macaca nemestrina) macaques is related to early maternal experiences. Am J Primatol 62:243-259.
71. Werstuck GH, Kim AJ, Brenstrum T, Ohnmacht SA, Panna E, Capretta A (2004). Examining the correlations between GSK-3 inhibitory properties and anticonvulsant efficacy of valproate and valproate-related compounds. Bioorg Med Chem Lett 14:5465-5467.
72. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110.
73. Wu X, Chen PS, Dallas S,Wilson B, Block ML,Wang CC, et al. (2008). Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 11:1123-1134.
74. Yamawaki Y, Fuchikami M, Morinobu S, Segawa M, Matsumoto T, Yamawaki S (2012). Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus.World. J Biol Psychiatry 13:458-467.
75. Yu HS, Kim SH, Park HG, Kim YS, Ahn YM (2011). Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates tyrosine hydroxylase through extracellular signal-regulated kinase in rat striatum. Neurochem Int 59:779-786.
76. Zarate CA Jr, Singh J, Manji HK (2006). Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006-1020.